BLACK mobile logo

united states

How Eric Dane gave his final months to 'moving the needle' on ALS

February 20, 2026

Eric Dane, the 53-year-old actor famous for his role in Grey's Anatomy, has passed away less than a year after publicly revealing his ALS diagnosis in April 2025. During his final months, he dedicated himself to fundraising and advocacy work, helping launch campaigns that raised over $500,000 and joining the board of Target ALS while pushing for more than $1 billion in federal research funding. The actor also raised awareness through his craft, appearing in a medical drama portraying an ALS patient and speaking publicly about the urgent need to combat the disease despite bureaucratic obstacles.

Who is affected

  • Eric Dane (deceased actor, age 53)
  • ALS patients and their families
  • Eric Dane's children (referenced as he introduced himself as "a father")
  • Grey's Anatomy co-star Patrick Dempsey
  • Target ALS organization and its board of directors
  • Researchers studying ALS treatments and cures
  • The broader ALS community and advocacy organizations

What action is being taken

  • No explicit ongoing actions are stated in the article. (The article describes actions Dane took before his death, such as fundraising campaigns and appearing on television, but these are past actions. Current research efforts are mentioned generally but not described as specific ongoing initiatives.)

Why it matters

  • This matters because ALS is a rare, aggressive, and incurable disease that kills 90% of patients within five years, yet it receives insufficient research funding and faces significant challenges in clinical trials due to its rarity and rapid progression. Dane's high-profile advocacy work helped raise both funds and public awareness about a condition that lacks a single unifying cause and cannot be detected until irreversible nerve damage has occurred. His efforts highlight the critical need for sustained, major funding over many years to make progress toward treatments and a cure, similar to investments required for other neurodegenerative diseases like Alzheimer's and Parkinson's.

What's next

  • No explicit next steps stated in the article

Read full article from source: BBC